Professor
Alfred Health-Monash University
Melbourne, Victoria, Australia
Professor Andrew Spencer is Head of the Malignant Haematology, Transplantation and Cellular Therapy Service at The Alfred Hospital, Professor of Haematology at Monash University and Head of the Myeloma Research Group, all in Melbourne, Australia. He moved The Alfred Hospital in 1999, was appointed Head of Malignant Haematology, Transplantation and Cellular Therapy Service in 2007 and established an early phase haematology clinical trials unit in 2009, with currently over 194 blood cancer trials open and >800 registered trial patients. He has >320 peer reviewed publications with over 32,000 citations. Since 2020 he has been an invited speaker at over 50 international meetings on genomics, therapeutics and disease monitoring in multiple myeloma and is an invited investigator of the International Myeloma Foundation (IMF) Black Swan Research Initiative. He serves as an advisor to the IMF and the International Myeloma Working Group. He Chairs the Myeloma and Related Diseases Registry (MRDR), the APAC MRDR and the associated M1000 liquid biopsy biobank. He established the Australasian Myeloma Research Consortium (AMaRC) in 2016.
Disclosure information not submitted.
Thursday, September 18, 2025
12:00 - 12:50 East Coast USA Time